We are live on ! Find out more
SMA

Seven Mile Advisory Portfolio holdings

AUM $139M
1-Year Est. Return 26.01%
This Fund
S&P 500
This Quarter Est. Return
+13.29%
1 Year Est. Return
+26.01%
3 Year Est. Return
+102.71%
5 Year Est. Return
10 Year Est. Return
AUM
$115M
AUM Growth
+$20.1M
Cap. Flow
+$8.01M
Cap. Flow %
6.94%
Top 10 Hldgs %
45.5%
Holding
156
New
28
Increased
77
Reduced
26
Closed
6

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$248K
2
GILD icon
Gilead Sciences
GILD
+$220K
3
BTI icon
British American Tobacco
BTI
+$206K
4
SNY icon
Sanofi
SNY
+$206K
5
UL icon
Unilever
UL
+$204K

Sector Composition

Rank Sector Weight
1 Technology 22.42%
2 Communication Services 9.31%
3 Financials 7.66%
4 Healthcare 6.24%
5 Consumer Discretionary 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZN icon
151
AstraZeneca
AZN
$263B
-1,833
Closed -$248K
BTI icon
152
British American Tobacco
BTI
$131B
-6,572
Closed -$206K
GILD icon
153
Gilead Sciences
GILD
$162B
-2,941
Closed -$220K
SNY icon
154
Sanofi
SNY
$103B
-3,845
Closed -$206K
UL icon
155
Unilever
UL
$137B
-3,673
Closed -$204K

Similar funds

Seven Mile Advisory's Q4 2023 Portfolio in Review

As of Q4 2023, Seven Mile Advisory held 156 positions worth $115M, up 21% from $95.2M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Seven Mile Advisory deployed $8.01M of net new capital in Q4 2023, opening 28 new positions and adding to 77 existing holdings. Its largest new stake was NextEra Energy: 4,538 shares worth $276K.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $89.3K trimmed.

  • Seven Mile Advisory's largest Q4 2023 buy was NextEra Energy: 4,538 shares worth $276K.
  • Seven Mile Advisory added most to iShares Russell 1000 Growth ETF in Q4 2023, an estimated $574K increase.
  • Seven Mile Advisory's biggest Q4 2023 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $89.3K.
  • Seven Mile Advisory fully exited AstraZeneca in Q4 2023, selling an estimated $248K.
  • Seven Mile Advisory's ten largest holdings make up 46% of its $115M portfolio in Q4 2023.
  • Seven Mile Advisory opened 28 new positions and closed 6 in Q4 2023.
  • Seven Mile Advisory's portfolio value rose 21% quarter-over-quarter to $115M.

Based on Seven Mile Advisory's 13F filing for Q4 2023, filed 9 Feb 2024.